HOME - The Journal of Precision Medicine

LATEST NEWS

Bristol Myers Squibb Receives Approval for Abecma (idecabtagene vicleucel), the First CAR T Therapy Approved for the Treatment of Multiple Myeloma in Japan

adminpmls20162022-01-27T19:53:51-05:00January 27th, 2022|

Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

adminpmls20162022-01-27T19:47:21-05:00January 27th, 2022|

Active Motif Incorporated Announces the Acquisition of Amaryllis Nucleics and their proprietary RNASeq workflow

adminpmls20162022-01-27T19:43:42-05:00January 27th, 2022|

Flatiron Health Announces RWD Partnership with Japan’s NCCHE

adminpmls20162022-01-27T19:41:34-05:00January 27th, 2022|

PGDx Announces an Updated Medicare Reimbursement Rate for the elio™ tissue complete Test

adminpmls20162022-01-27T09:26:05-05:00January 27th, 2022|

Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Cancer

adminpmls20162022-01-19T19:14:56-05:00January 19th, 2022|

Paige Announces Executive Leadership Appointments

adminpmls20162022-01-19T19:10:10-05:00January 19th, 2022|

M2GEN Expands Leadership Team, Appointing Daniel Elgort, Ph.D. as Chief Data and Analytics Officer and May Yoon as Chief People Officer

adminpmls20162022-01-19T19:06:16-05:00January 19th, 2022|

Blueprint Medicines Provides 2022 Portfolio Goals Targeting Expanded Precision Therapy Leadership

adminpmls20162022-01-19T19:03:43-05:00January 19th, 2022|

Bristol Myers Squibb Receives Approval for Abecma (idecabtagene vicleucel), the First CAR T Therapy Approved for th… twitter.com/i/web/status/1…
12 hours ago
Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation… twitter.com/i/web/status/1…
12 hours ago
Active Motif Incorporated Announces the Acquisition of Amaryllis Nucleics and their proprietary RNASeq workflow - thejournalofprecisionmedicine.com/active-motif-i…
12 hours ago

LATEST ISSUE

The Journal of Precision Medicine - December 2021

The impacts of biomarkers on precision

Pfizer’s Precision Medicine Pipeline and Technology Portfolio

Legal and Liability Implications of Pharmacogenomics for Physicians and Pharmacists

New Genomic and Epigenetic Profiling Assays Are Blueprints for the Development of Comprehensive Biomarker Testing for Cancer

Integration of gene expression profiling and artificial intelligence into personalized diagnostics for improved patient care

DNA Synthesis – An Integral Force in the Founding and Future of Precision Medicine

Putting PGx into Practice

CE and the SCIEX BioPhase 8800 in Precision Medicine

Advancing Spatial Biology through Highly Multiplexed Protein Imaging: The Orion™ Platform

The essentials for a powerful clinical decision support software with embedded PGx: Evidence driven platform integrated into an EHR

Part 2 – Surveillance of Wastewater and Prevention Platform (SWAPP): A Case Study of Digital Public Health and SARS-CoV-2

Tumor Glycolipids, a New Frontier for Early Detection and Precision Medicine in Ovarian Cancer and Other Malignancies

Novel Physiological Vital Sign for Behavioral Health

Colon Cancer – A Review

Research at Cedars Sinai – CANCER

ARCHIVE ISSUES

September 2021

Articles include:
The Integration of Personalized Medicine into Healthcare: Advancing the Promise to More Patients, The value of adding RNA sequencing to precision biomarker strategy, As Targeted Therapies Expand Beyond Cancer, Companion Diagnostics Must Improve.

Read More

June 2021

Articles include:
myRabble: A novel patient platform to improve access to personalized medicine, Clinical data and precision medicine: The urgent need for in‑house NGS capabilities at community hospitals.

Read More

March 2021

Articles include:
Integrating biomarker and translational research in a drug development pipeline, Early Detection of Cancer: Transitioning from Emerging to Established Companies and Technologies.

Read More

The Journal of Precision Medicine - December

December 2020

Articles include:
Letter to the Journal: The COVID-19 innovation race, a case study
Personalised Medicine and Disease Modification in Osteoarthritis: On our journey but still a way to go!

Read More

LATEST NEWS

Bristol Myers Squibb Receives Approval for Abecma (idecabtagene vicleucel), the First CAR T Therapy Approved for the Treatment of Multiple Myeloma in Japan

Lifebit partners with NIHR Cambridge Biomedical Research Centre to launch the CYNAPSE platform for next-generation genomics research

Active Motif Incorporated Announces the Acquisition of Amaryllis Nucleics and their proprietary RNASeq workflow

Flatiron Health Announces RWD Partnership with Japan’s NCCHE

PGDx Announces an Updated Medicare Reimbursement Rate for the elio™ tissue complete Test

Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Cancer

Paige Announces Executive Leadership Appointments

M2GEN Expands Leadership Team, Appointing Daniel Elgort, Ph.D. as Chief Data and Analytics Officer and May Yoon as Chief People Officer

Blueprint Medicines Provides 2022 Portfolio Goals Targeting Expanded Precision Therapy Leadership

Recent Tweets

LATEST ISSUE

ARCHIVE ISSUES

September 2021

June 2021

March 2021

December 2020

SUBSCRIBE